PA
AURA icon

Parallel Advisors’s Aura Biosciences AURA Stock Holding History

Parallel Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.2K Hold
5,665
– – ﹤0.01% 2281
2026
Q1 		$37.9K Buy
5,665
+3,206
+130% +$18.4K ﹤0.01% 2152
2025
Q4 		$13.4K Buy
2,459
+2,380
+3,013% +$14.1K ﹤0.01% 2492
2025
Q3 		$488 Hold
79
– – ﹤0.01% 3331
2025
Q2 		$495 Buy
+79
New +$462 ﹤0.01% 3303

Other funds holding AURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
TGAM
TBH Global Asset Management Brentwood, Tennessee $546M AUM 26.68% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

Parallel Advisors's AURA Position: Q2 2026 in Review

Parallel Advisors held its Aura Biosciences (AURA) position steady in Q2 2026 at 5,665 shares worth $40.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2281.

Parallel Advisors first reported a position in AURA in Q2 2025 and has held it in 5 quarters since. 40 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Parallel Advisors held 5,665 shares of Aura Biosciences worth $40.2K as of Q2 2026.
  • Parallel Advisors left its Aura Biosciences share count unchanged in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2281 holding.
  • Parallel Advisors first reported a position in Aura Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 40 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.